Proteins binding HER2, NKG2D and CD16
US11884732B2 · kind B2 · utility
3Cited by
50References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 20, 2018 |
| Grant date | Jan 30, 2024 |
| Priority date | — |
| Expiry date | Apr 28, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Multi-specific binding proteins that bind HER2, the NKG2D receptor, and CD 16 are described, as well as pharmaceutical compositions and therapeutic methods useful for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.